Cantor Fitzgerald L. P. Has $1.63 Million Stock Holdings in M3-Brigade Acquisition V Corp. $MBAV

Cantor Fitzgerald L. P. lifted its holdings in shares of M3-Brigade Acquisition V Corp. (NASDAQ:MBAVFree Report) by 836.2% in the third quarter, according to its most recent filing with the SEC. The firm owned 154,338 shares of the company’s stock after acquiring an additional 137,853 shares during the period. Cantor Fitzgerald L. P. owned approximately 0.43% of M3-Brigade Acquisition V worth $1,628,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the business. Heights Capital Management Inc. bought a new stake in M3-Brigade Acquisition V in the third quarter valued at about $5,275,000. Meteora Capital LLC raised its position in M3-Brigade Acquisition V by 133.0% in the third quarter. Meteora Capital LLC now owns 1,475,801 shares of the company’s stock worth $15,570,000 after purchasing an additional 842,418 shares in the last quarter. Whitebox Advisors LLC lifted its stake in M3-Brigade Acquisition V by 18.2% during the third quarter. Whitebox Advisors LLC now owns 130,000 shares of the company’s stock worth $1,372,000 after purchasing an additional 20,000 shares during the period. Susquehanna International Group LLP acquired a new stake in M3-Brigade Acquisition V during the third quarter valued at approximately $586,000. Finally, Prelude Capital Management LLC acquired a new stake in M3-Brigade Acquisition V during the third quarter valued at approximately $281,000.

M3-Brigade Acquisition V Trading Up 0.4%

Shares of M3-Brigade Acquisition V stock opened at $10.70 on Thursday. M3-Brigade Acquisition V Corp. has a 12-month low of $10.19 and a 12-month high of $13.73. The company has a 50-day simple moving average of $10.68 and a 200 day simple moving average of $10.63.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on MBAV. Wall Street Zen raised M3-Brigade Acquisition V to a “sell” rating in a report on Saturday, March 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research note on Monday, December 22nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

View Our Latest Stock Analysis on MBAV

M3-Brigade Acquisition V Company Profile

(Free Report)

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.

Further Reading

Institutional Ownership by Quarter for M3-Brigade Acquisition V (NASDAQ:MBAV)

Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.